The Effect of Nicardipine on Kidney Function During Orthognathic Surgery Under Hypotensive Anesthesia

NCT01175746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2013-06-13

No results posted yet for this study

Summary

Since nicardipine is known to protect kidney function, nicardipine infusion will result in better renal parameters measured in this study.

Conditions

  • Healthy Subjects

Interventions

DRUG

Nicardipine

DRUG

remifentanil

0.1-0.5 ugkg/min during hypotensive anesthesia

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Ji Young Kim · Severance hospital, YUHS

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-06-30
Completion
2011-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01175746 on ClinicalTrials.gov